CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2025	Apr. 30, 2024
Cash flows from operating activities:
Net income	$ 1,280	$ 2,139
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	2,280	2,288
Transactional losses/(gains)	893	(1,434)
Provision for inventories and accounts receivable	1,307	1,210
Deferred income taxes	(2,847)	(457)
Stock-based compensation	1,192	1,838
Other	25	82
Changes in assets and liabilities:
Trade receivables	9,555	3,384
Inventories	(26,662)	(15,687)
Other current assets	1,014	(5,090)
Accounts payable	(2,869)	1,082
Accrued liabilities	4,150	2,817
Accrued payroll and benefits	992	(1,257)
Income taxes receivable	2,720	4,714
Income taxes payable	(550)	(13,785)
Other non-current assets	290	95
Other non-current liabilities	16	(13)
Net cash used in operating activities	(7,214)	(18,074)
Cash flows from investing activities:
Capital expenditures	(1,533)	(1,624)
Long-term investments	(1,290)	(3,123)
Trademarks and other intangibles	(14)	(49)
Net cash used in investing activities	(2,837)	(4,796)
Cash flows from financing activities:
Dividends paid		(7,773)
Stock repurchases		(1,086)
Stock awards and options exercised and other changes	(467)	(1,058)
Net cash used in financing activities	(467)	(9,917)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	5,177	(3,948)
Net decrease in cash, cash equivalents and restricted cash	(5,341)	(36,735)
Cash, cash equivalents, and restricted cash at beginning of year	209,214	262,814
Cash, cash equivalents, and restricted cash at end of period	203,873	226,079
Non-cash financing activities:
Dividends declared but not paid	7,783
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	203,086	225,372
Restricted cash included in other non-current assets	787	707
Cash, cash equivalents, and restricted cash at end of period	$ 203,873	$ 226,079